I agree that this site is using cookies. You can find further informations here.
X
Yeo, Karen Rowland
202  results:
Search for persons X
?
1

Evaluation of the drug–drug interaction potential of brigat..:

Hanley, Michael J. ; Yeo, Karen Rowland ; Tugnait, Meera...
CPT: Pharmacometrics & Systems Pharmacology.  13 (2024)  4 - p. 624-637 , 2024
Link: https://doi.org/10.1002/..
 
?
2

Integration of cyp and non-cyp hepatic abundance changes in..:

Hatley, Oliver ; Johnson, Trevor ; Gardner, Iain.
Drug Metabolism and Pharmacokinetics.  55 (2024)  - p. 100971 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Inclusion of Obese Participants in Drug Development: Reflec..:

Shen, Jinshan ; Moore, Kenneth T. ; Shukla, Suneet...
The Journal of Clinical Pharmacology.  64 (2023)  1 - p. 13-18 , 2023
Link: https://doi.org/10.1002/..
 
?
4

Supplementing clinical lactation studies with PBPK modeling..:

Pan, Xian ; Abduljalil, Khaled ; Almond, Lisa M...
CPT: Pharmacometrics & Systems Pharmacology.  13 (2023)  3 - p. 386-395 , 2023
Link: https://doi.org/10.1002/..
 
?
5

A physiologically based pharmacokinetic - pharmacodynamic m..:

Mendes, Mailys De Sousa ; Hatley, Oliver ; Gill, Katherine Linda..
European Journal of Pharmaceutical Sciences.  150 (2020)  - p. 105355 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Assessing pharmacokinetic differences in Caucasian and East..:

Zhou, Li ; Sharma, Pradeep ; Yeo, Karen Rowland...
European Journal of Pharmaceutical Sciences.  139 (2019)  - p. 105061 , 2019
Link: https://doi.org/10.1016/..
 
?
7

Application of permeability-limited physiologically-based p..:

Neuhoff, Sibylle ; Yeo, Karen Rowland ; Barter, Zoe...
Journal of Pharmaceutical Sciences.  102 (2013)  9 - p. 3145-3160 , 2013
Link: https://doi.org/10.1002/..
 
?
8

Application of permeability‐limited physiologically-based p..:

Neuhoff, Sibylle ; Yeo, Karen Rowland ; Barter, Zoe...
Journal of Pharmaceutical Sciences.  102 (2013)  9 - p. 3161-3173 , 2013
Link: https://doi.org/10.1002/..
 
?
9

Application of in vitro-in vivo extrapolation (IVIVE) and p..:

Yeo, Karen Rowland ; Kenny, Jane R. ; Rostami-Hodjegan, Amin
European Journal of Clinical Pharmacology.  69 (2013)  6 - p. 1311-1320 , 2013
Link: https://doi.org/10.1007/..
 
?
10

Theoretical assessment of a new experimental protocol for d..:

Yang, Jiansong ; Jamei, Masoud ; Yeo, Karen Rowland..
European Journal of Pharmaceutical Sciences.  31 (2007)  3-4 - p. 232-241 , 2007
Link: https://doi.org/10.1016/..
 
?
11

The effect of chronic tobacco smoking on arterial stiffness:

Rehill, Nirandeep ; Beck, Charles R. ; Yeo, Karen Rowland.
British Journal of Clinical Pharmacology.  61 (2006)  6 - p. 767-773 , 2006
Link: https://doi.org/10.1111/..
 
?
12

Kinetic values for mechanism-based enzyme inhibition: Asses..:

Yang, Jiansong ; Jamei, Masoud ; Yeo, Karen Rowland..
European Journal of Pharmaceutical Sciences.  26 (2005)  3-4 - p. 334-340 , 2005
Link: https://doi.org/10.1016/..
 
?
13

Inhibitory effects of verapamil and diltiazem on simvastati..:

Yeo, Karen Rowland ; Yeo, Wilfred W.
British Journal of Clinical Pharmacology.  51 (2001)  5 - p. 461-470 , 2001
Link: https://doi.org/10.1046/..
 
?
14

Dose Optimization Informed by PBPK Modeling: State‐of‐the A..:

Rowland Yeo, Karen ; Gil Berglund, Eva ; Chen, Yuan
Clinical Pharmacology & Therapeutics.  , 2024
Link: https://doi.org/10.1002/..
 
?
15

Physiologically Based Pharmacokinetic Modeling to Determine..:

Pan, Xian ; Rowland Yeo, Karen
Clinical Pharmacology & Therapeutics.  114 (2023)  1 - p. 182-191 , 2023
Link: https://doi.org/10.1002/..
 
1-15